Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bittium Corporation: SHARE REPURCHASE 7.8.2023

Bittium Corporation  ANNOUNCEMENT  7.8.2023 Bittium Corporation: SHARE REPURCHASE 7.8.2023 In the Helsinki Stock Exchange Trade date           7.8.2023Bourse trade         BuyShare                  BITTIAmount             2 400 SharesAverage price/ share    3,9500 EURTotal cost            9 480,00 EUR Bittium Corporation now holds a total of 124 472 sharesincluding the shares repurchased on 7.8.2023 On behalf of Bittium Corporation Nordea Bank Oyj

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B23K0M20 Issuer Name CAPITA PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Schroders Plc City of registered office (if applicable) London Wall, Barbican Country of registered office (if applicable) England 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

#23-255 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Veg of Lund signs letter of intent for distribution and sales of DUG in Italy

Veg of Lund has signed a Letter of Intent (“LOI”) with Romagnoli F.lli S.p.A. The companies will cooperate with the common goal of selling, marketing and distributing Veg of Lund’s products under the DUG® brand in Italy.“The letter of intent is a continuation of implementing the strategy of partly distribution-based business model to complement license and direct sales. Romagnoli F.lli S.p.A is one of the leading Italian companies active in the processing and marketing of fruit and vegetables, especially potatoes. Romagnoli F.lli S.p.A is an excellent partner for our potato-based products

Buy-back of shares in Hemnet during 31 July - 4 August, 2023

Hemnet Group AB (publ) (LEI code: 5493008VIU67J3HUAR07) ("Hemnet") has during 31 July  to 4 August 2023 repurchased in total 51,894 own ordinary shares (ISIN code: SE0015671995) as part of the share buy-back program initiated by the board of directors of Hemnet in order to adjust Hemnet's capital structure.The share buy-backs form part of the share buy-back program of maximum SEK 450,000,000 announced by Hemnet on 27 April 2023. The share buy-back program is being carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation

Crayfish BidCo Oy supplements the tender offer document dated 7 March 2023 regarding its voluntary public cash tender offer for all shares in Caverion Corporation

Caverion Corporation Tender Offer 7 August 2023 at 4.55 p.m. EESTCrayfish BidCo Oy supplements the tender offer document dated 7 March 2023 regarding its voluntary public cash tender offer for all shares in Caverion Corporation NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. On 10 January 2023,

Image Systems’ business area Motion Analysis receives an order of approx. MSEK 1.1 from the Italian Defense

The order includes the ordering of the software TrackEye and training thereof."The Italian Armed Forces have long been users of Image Systems' software for analysis and testing of various defense systems. They are used today at most of the military test sites in Italy. We are proud of continued trust," says Ohad Zangi, head of Image Systems' business area Motion Analysis.

Optomed Plc - Managers' transactions - Mäkinen

Optomed Plc - Managers' Transactions – 7 August  2023 at 16.00 EET Optomed Plc - Managers' transactions - Mäkinen ____________________________________________ Person subject to the notification requirement Name: Mäkinen, Seppo Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20230807115550_17 ____________________________________________ Transaction date: 2023-08-07 Venue not applicable Instrument type: SHARE ISIN: FI4000410881

Optomed Plc - Managers' transactions - Lee

Optomed Plc - Managers' Transactions – 7 August  2023 at 16.00 EET Optomed Plc - Managers' transactions - Lee ____________________________________________ Person subject to the notification requirement Name: Lee, Ty Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20230807115550_16 ____________________________________________ Transaction date: 2023-08-07 Venue not applicable Instrument type: SHARE ISIN: FI4000410881 Nature of

Optomed Plc - Managers' transactions - Calarco

Optomed Plc - Managers' Transactions – 7 August  2023 at 16.00 EET Optomed Plc - Managers' transactions - Calarco ____________________________________________ Person subject to the notification requirement Name: Calarco, Catherine Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20230807115550_15 ____________________________________________ Transaction date: 2023-08-07 Venue not applicable Instrument type: SHARE ISIN: FI4000410881

Optomed Plc - Managers' transactions - Tauriainen

Optomed Plc - Managers' Transactions – 7 August  2023 at 16.00 EET Optomed Plc - Managers' transactions - Tauriainen ____________________________________________ Person subject to the notification requirement Name: Tauriainen, Reijo Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20230807115550_19 ____________________________________________ Transaction date: 2023-08-07 Venue not applicable Instrument type: SHARE ISIN:

Optomed Plc - Managers' transactions - Salonen

Optomed Plc - Managers' Transactions – 7 August  2023 at 16.00 EET Optomed Plc - Managers' transactions - Salonen ____________________________________________ Person subject to the notification requirement Name: Salonen, Petri Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20230807115550_18 ____________________________________________ Transaction date: 2023-08-07 Venue not applicable Instrument type: SHARE ISIN: FI4000410881

Optomed Plc - Managers' transactions - Tenstam

Optomed Plc - Managers' Transactions – 7 August  2023 at 16.00 EET Optomed Plc - Managers' transactions - Tenstam ____________________________________________ Person subject to the notification requirement Name: Tenstam, Anna Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20230807115550_20 ____________________________________________ Transaction date: 2023-08-07 Venue not applicable Instrument type: SHARE ISIN: FI4000410881

Change in Optomed’s holding of treasury shares

Optomed Plc Stock Exchange Release 7 August 2023 at 15.30, Helsinki Change in Optomed’s holding of treasury shares Optomed has conveyed 15,093 treasury shares to the members of the Board of Directors as a part of the Board members' annual remuneration in accordance with the decision of the Annual General Meeting 2023. The amount of shares is based on the monthly remuneration decided by the Annual General Meeting and Optomed's value weighted average share price between 28 July and 3 August 2022.     A total of 1,000 of shares have been subscribed for under the Company’s stock

Development of Alisa Bank's loan and deposit portfolio in July

ALISA BANK PLC PRESS RELEASE 7.8.2023 AT 15.30 EESTIn July 2023, Alisa Bank provided financing worth of EUR 23.9 million. The loan portfolio totaled EUR 157.8 million and deposits totaled EUR 249.4 million at the end of the month. In July, the number of customers was about 51 900. Alisa Pankki raised the interest rate on both the savings account and term deposits again in July, offering very competitive interest rates to savers. On savings account, Alisa Bank’s customers now receive 3.0% interest and on term deposits up to 3.3%, depending on the length of the deposit period. Alisa

Alisa Bank Plc will publish the January-June 2023 half-year report on Friday, 18 August 2023

ALISA BANK PLC PRESS RELEASE 7.8.2023 AT 14.45 EESTAlisa Bank Plc will publish the half-year report for the period 1 January to 30 June 2023 on Friday, 18 August 2023 at approximately 9:00 a.m. Finnish time. At that time, the half-year report is available on the company's website . Alisa Bank's CEO Teemu Nyholm will present the main points of the half-year report to analysts, investors, and the media in a webcast on the same day at 10:00 a.m. Finnish time. The webcast will be held in Finnish. At the end of the presentation,

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions 7.8.2023 at 14.00Glaston Oyj Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Päivi LindqvistPosition: Chief Financial OfficerIssuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62Notification type: INITIAL NOTIFICATIONReference number: 36282/5/4 ____________________________________________Transaction date: 2023-08-03Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000369657Nature of transaction: RECEIPT OF A

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions  7.8.2023 at 14.00Glaston Oyj Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Sasu KoivumäkiPosition: Other senior managerIssuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62Notification type: INITIAL NOTIFICATIONReference number: 36279/4/4 ____________________________________________Transaction date: 2023-08-03Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000369657Nature of transaction: RECEIPT OF A

Terveystalo Plc: Managers' Transactions, Juuso Pajunen

Terveystalo Plc, Managers’ transactions, 7 August 2023 at 14:00 EEST ____________________________________________ Person subject to the notification requirement Name: Juuso Pajunen Position: Chief Financial Officer Issuer: Terveystalo Oyj LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 36249/5/4 ____________________________________________ Transaction date: 2023-08-07 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000252127 Nature of transaction: ACQUISITION ___________________________________

Navamedic ASA: Invitation to 2023 2nd quarter presentation

Oslo, August 7, 2023 - Navamedic ASA (OSE: Nava) will be presenting its second quarter 2023 results and publish its first half 2023 report on Friday, August 11, 2023. The presentation will be held at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presentation will be available through the Navamedic web site on the following link: https://navamedic.com/investors/financial-results/ For further information, please contact: Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail: kathrine@navamedic.com Lars Hjarrand,CFO, +47 917 62 842 E-

Per Widerström leaves Nordnet’s Board of Directors

Board member Per Widerström has announced his intentions to leave Nordnet’s Board of Directors. Widerström has accepted the role as CEO of the gaming company 888 Holdings PLC and will not be able to commit enough time to both assignments.Per Widerström was elected as board member of Nordnet during 2017 in connection with the Nordic Capital investment and subsequent delisting from the stock exchange. In addition to being a board member, Widerström has also served as the Chairman of Nordnet’s IT Committee. Widerström will during the fall assume the role as CEO of the gaming company 888 which

#23-72 Unit issue in Hemply Balance Holding AB

The annual general meeting in Hemply Balance Holding AB (the “Company”), held on June 30, 2023, has decided on a unit issue with preferential rights for the Company’s existing shareholders.   The last day of trading in the Company’s shares including the right to receive unit rights is August 11, 2023. The first day of trading in the Company’s shares excluding the right to receive unit rights is August 14, 2023. The record date is August 15, 2023.   The shareholders of the Company will receive one (1) unit right for each (1) share held per the record date. Two (2) unit rights are

Eternali signs first customer order

Skogsaktiebolaget Eternali ("Eternali") has signed its first order for delivery of wood raw material to a customer in Europe. The buyer is BSL Comércio Internacional S.A., a Portuguese trading company that operates large volumes of wood fibre to the international market. The order is for a first shipment of 10,000 tons of wood raw material.The signed agreement with BSL is for a first order with shipment during 2023 with a value of approximately SEK 7 million. The plan for the new partnership with BSL is then to continue with ongoing deliveries by larger volumes following the first shipment.

ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.

ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Company has entered through its Polish subsidiary into a collaboration agreement (“Agreement”) with Synoptis Pharma Sp. Z o.o. (“Synoptis”) under which ODI becomes the exclusive supply partner for medicinal cannabis flos products to Synoptis for a period of 5 plus additional optional 3.5 years covering all Eastern and South Eastern European markets, including Poland, Czech Republic, Ukraine, Croatia etc.Milestone for ODI ODI has secured a prime pharmaceutical company in the Eastern European markets as its collaboration

There are no items matching the current filter
There are no more items matching the current filter
Back to top